EO 14336
Ensuring American Pharmaceutical Supply Chain Resilience by Filling the Strategic Active Pharmaceutical Ingredients Reserve
HealthcareNational SecurityEconomy & Trade
Ad Space (leaderboard)
Summary
This executive order directs the Department of Health and Human Services to establish and fill the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR) with a 6-month supply of active pharmaceutical ingredients (APIs) for approximately 26 critical medicines. The order aims to reduce U.S. dependence on foreign sources for essential medicine components and domestic pharmaceutical supply chain resilience.
Key Points
- 1Directs the Office of the Assistant Secretary for Preparedness and Response (ASPR) to identify 26 critical medicines and develop a list within 30 days
- 2Requires obtaining a 6-month supply of APIs for these critical medicines, with preference for domestically manufactured ingredients, using existing available federal funds
- 3Mandates readying an existing SAPIR repository within 120 days and stocking it within 30 days after certification
- 4Requires a plan within 90 days to expand the reserve to cover 86 essential medicines on an updated list and proposes opening a second repository within 1 year
- 5Addresses the current domestic production gap where only about 10 percent of APIs used in the U.S. are domestically manufactured
This summary is for informational purposes only. It may not capture all nuances of the executive order. Always refer to the official text for authoritative information.
Ad Space (rectangle)